As the U.S. Food and Drug Administration (FDA) continues to defy mounting requests from the U.S. Congress and the natural products industry to provide science-based and public health regulations for CBD, more states are rushing in to fill the vacuum. New Hampshire recently became the latest state to propose new state regulations for consumable hemp and CBD products.
Kyle Turk, director for government affairs, for the Natural Products Association (NPA) testified in a public hearing before the Environment and Agriculture Committee on Jan. 27, 2021 in support of HB 272.
“The states continue to demonstrate that it is possible to take action on CBD products while managing the COVID-19 health crisis,” said Turk, “The pandemic is not an excuse for the FDA to skirt its responsibilities to protect public health in other areas. We applaud the states for taking action to regulate CBD, and we will continue to lead the conversations guiding states to establish a regulatory pathway for CBD. Over the last two years, NPA has worked with policymakers across the country, including in New Jersey, Utah, Rhode Island and Georgia, to establish a regulatory framework for CBD products. No other organization has had a greater impact shaping CBD policy at the state level than NPA.”
To viewNPA’s testimony, visit www.npanational.org/wp-content/uploads/2021/01/NH-HB-272-Testimony.pdf.
